PHARMA MAR, S.A. «12345...» Page 4 out of 10 from 01/07/1988 to 22/03/2018 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 01/06/2017 17:45 PHARMA MAR, S.A. Increases and decreases of share capital. - Trading: admissions, changes and removals The Company announces the admission to trading of the shares relating to the share capital increase Register number: 252694 29/05/2017 19:23 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks. - Announcements of public presentations and meetings Sylentis, S.A.U. has initiated the first Phase III study, HELIX, with its investigational drug SYL1001 for the treatment of dry eye syndrome Register number: 252585 26/05/2017 18:44 PHARMA MAR, S.A. Increases and decreases of share capital The Company announces that the public deed for the share capital increase fully subscribed and paid up by Specialised Therapeutics Investments Pty LTD ATF The Specialised Therapeutics Unit Trust, has been duly registered. Register number: 252547 26/05/2017 14:39 PHARMA MAR, S.A. Announcements and resolutions of general shareholders meetings The Company announces the decision of the Board of Directors to call the General Shareholders´ Meeting on 28/06/2017 and 29/06/2017, respectively, on first and second call notice. The Company sends notice of call and proposed resolutions. Register number: 252524 Related with 254038 of 29/06/2017 (14:04) 25/05/2017 19:13 PHARMA MAR, S.A. Shareholders agreements affecting voting rights The Company communicates the provision which constitute “shareholders agreements” included in the Subscription Agreement, described in the regulatory announcement number 252,144. Register number: 252480 24/05/2017 13:04 PHARMA MAR, S.A. Liquidity contracts and specialists The Company announces that has entered into a liquidity agreement with Mediación Bursátil, Sociedad de Valores, S.A. Register number: 252408 18/05/2017 18:35 PHARMA MAR, S.A. Increases and decreases of share capital The Company announces the granting of the public deed for the share capital increase fully subscribed and paid up by Specialised Therapeutics Investments Pty LTD ATF The Specialised Therapeutics Unit Trust. Register number: 252207 18/05/2017 16:24 PHARMA MAR, S.A. Liquidity contracts and specialists The Company announces the termination of the liquidity agreement entered into on April, 29, 2016 with JB Capital Markets, Sociedad de Valores, S.A. Register number: 252178 17/05/2017 18:06 PHARMA MAR, S.A. Increases and decreases of share capital. - Strategic agreements with third parties PharmaMar and Specialised Therapeutics Asia (STA) have entered into a licensing agreement for PM1183 covering Oceania and several Asian countries. Pharma Mar has agreed a share capital increase to be fully subscribed by a company within STA Group. Register number: 252144 03/05/2017 19:33 PHARMA MAR, S.A. Liquidity contracts and specialists Pharma Mar submits transactions within the Liquidity Agreement corresponding to the period between 02/02/2017 and 01/05/2017. Register number: 251493 Related with 238044 of 29/04/2016 (13:54) Page 4 out of 10 «12345...»